RNA interference is a natural mechanism for living cells to control whether specific genes are being used or not.

June 30 (Reuters) - Hong Kong-listed drug design tech firm Metis TechBio said on Tuesday it has granted U.S.-based biotechnology firm Boulevard Bio exclusive global rights to develop, manufacture and ...

The promised industrial applications of quantum computers often rest on their anticipated ability to perform accurate, efficient quantum chemical calculations. Computational drug discovery relies on ...

In liver, lipid nanoparticles (LNPs) were first used to deliver patisiran, currently the only siRNA drug on the market that uses this technology platform. The animal POC studies of LNP-mediated siRNA ...

AI drug discovery cleared its first Phase IIa clinical test in 2025, as BIO 2026 confirmed the shift from speculation to ...

Google DeepMind announced the launch of AlphaProteo, an AI system to help biological and health researchers design novel, high-strength proteins that bind to target molecules with accuracy and ...

Experts have been raising concerns about “AI washing.” One of these experts, futurist Bernard Marr, has said that AI washing “involves exaggerating the capabilities of a product or service that is ...

The Shanghai International Computational Biology Challenge, a global competition to find and promote talent in the field of ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Founded in 2018, the company has built its foundation on regenerative cell therapy, including its lead programs for neonatal brain injury. Building on that foundation, Axiom is developing additional ...

Merck & Co. will partner with Protillion Biosciences to discover multiple new therapy candidates, through a collaboration ...

An international collaboration has developed AI-designed protein structures that self-assemble into virus-like nanocages ...